Equity to Asset ratio is calculated as total stockholders equity divided by total asset. enGene Holdings's Total Stockholders Equity for the quarter that ended in Jan. 2024 was $62.39 Mil. enGene Holdings's Total Assets for the quarter that ended in Jan. 2024 was $93.42 Mil.
The historical rank and industry rank for enGene Holdings's Equity-to-Asset or its related term are showing as below:
ENGN'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.56 Med: -0.45 Max: 0.83
Current: 0.67
During the past 4 years, the highest Equity to Asset Ratio of enGene Holdings was 0.83. The lowest was -1.56. And the median was -0.45.
ENGN's Equity-to-Asset is ranked better than 50.73% of 1565
companies
in the Biotechnology industry
Industry Median: 0.67
vs ENGN: 0.67
enGene Holdings Equity-to-Asset Historical Data
The historical data trend for enGene Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of enGene Holdings's Equity-to-Asset
For the Biotechnology subindustry, enGene Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
enGene Holdings's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, enGene Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where enGene Holdings's Equity-to-Asset falls into.
enGene Holdings Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
enGene Holdings's Equity to Asset Ratio for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
enGene Holdings Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of enGene Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
enGene Holdings (enGene Holdings) Business Description
7171 Rue Frederick Banting, Saint-Laurent, QC, CAN, H4S 1Z9
Website
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENGN has been successfully added to your 